Skip to main content
Login
User menu
Mega menu
EASL
Resources
Resources
EASL Resources
All Resources
Basic Techniques in Experimental Hepatology at a Glance
Clinical Practice Guidelines
Congress Resources
COVID-19 Resources
EASL Molecular Tumour Boards
EASL Policy Dialogues
EASL Quiz
ePosters
EASL DeepDive
EASL Journal Club
Nurses and AHPs
Online Courses
On-demand Webinars
Podcasts
Slide Decks
Webcasts
Webinars Calendar
EASL-Related Resources
EHC On-demand Webinar
ERN Rare-Liver On-demand Webinars
Baveno VII - Consensus Workshop
Baveno VII - Pediatric Research Workshop
Industry Resources
All Resources
Industry Symposia - EASL Monothematic Conference 2023
Industry Symposia - International Liver Congress
Industry Symposia - Liver Cancer Summit
Industry Symposia - NAFLD Summit 2022
GSK Resources
Patient Resources
All Resources
COVID-19 Resources
Documents
ePosters
Infographics
Patient Guidelines
Podcasts
Slide Decks
Takeaways
Webcasts
EASL Studio
EASL Campus Connect
My Community
Explore Community
EASL Community Feed
All Topics
Community FAQ's
Create
Our Sponsors
Primary tabs
User menu
Resources 49
(current)
Session 49
Displaying results 25 - 36 of 49
Display:
12
24
48
Liver Tumours
Regorafenib in patients with unresectable hepatocellular carcinoma in routine clinical practice: Exploratory analysis of safet...
Webcasts
View
Liver Tumours
Panel Discussion
Webcasts
View
Liver Tumours
HCC risk stratification: for which purpose and how?
Webcasts
View
Liver Tumours
Future of radiology in liver cancer (to cover radiomics)
Webcasts
View
Liver Tumours
Metabolic profiling of CCA and HCCs
Webcasts
View
Liver Tumours
Clinical utility of circulating tumor DNA (ctDNA) in diagnosis and predicting therapeutic response
Webcasts
View
Liver Tumours
Immune component (histopathology view)
Webcasts
View
Liver Tumours
Current status of immunotherapy in HCC and CCA
Webcasts
View
Liver Tumours
Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry
Webcasts
View
Liver Tumours
Circulating vesicles hold etiology-related protein biomarkers of cholangiocarcinoma risk, early diagnosis and prognosis mirror...
Webcasts
View
Liver Tumours
Rationale for combination therapy
Webcasts
View
Liver Tumours
The role of CAFs in liver cancers
Webcasts
View
Pagination
First page
« First
Previous page
‹ previous
Page
1
Page
2
Current page
3
Page
4
Page
5
Next page
next ›
Last page
Last »
Explore Community
Community Stream
Easl Community Feed
My Feed
Browse Stream
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Privacy Policy
Cookie Policy